Skip to main content

Zevra Therapeutics, Inc 10-Q for FY2025 Q3

Zevra Therapeutics, Inc. (ZVRA)

10-Q 2025-11-05 For: 2025-09-30
View Original
Added on April 10, 2026

About this 10-Q

Zevra Therapeutics, Inc filed this 10-Q on November 5, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$26.06M
up 605.4% from $3.7M a year earlier
Net loss
$544K
compared with a net loss of $33.23M a year earlier
Diluted EPS
-$0.01
compared with -$0.69 a year earlier